Systemic allergic reactions to insect stings affect up to 5% of the population during their
lifetime, and up to 32% of beekeepers. Such reactions can be fatal, albeit very rarely, and …

Stinging insect allergy is responsible for more than 10% of all cases of anaphylaxis. The
potential culprit insects are diverse and vary with geography. The incidence of insect allergy …

Background An omalizumab treatment and a high maintenance venom dose may both help
to prevent recurrent systemic allergic reactions (SAR) to venom immunotherapy (VIT). The …

Bee venom (BV) therapy is a type of alternative medical treatment used to treat various
diseases in oriental medicine. The mechanisms underlying the effects of BV remain poorly …

Background The hypothetical risks of cardiovascular medication during Hymenoptera
venom immunotherapy (VIT) are still a matter of controversy. Objective To assess the …

Background Subcutaneous venom immunotherapy (VIT) represents an effective treatment
against bee venom allergy. However, it involves long treatment times, high costs, and the …

Abstract Purpose of Review We reviewed the existing evidence base to desensitisation for
food allergy, applying the Grading of Recommendations, Assessment, Development and …

Introduction: IgE-mediated bee venom allergy can be treated with allergen-specific
immunotherapy (AIT). Subcutaneous immunotherapy (SCIT) is time and cost intensive due …

The majority of risk factors for severe anaphylaxis are not modifiable. For patients presenting
with well defined risk factors for a very severe or even fatal anaphylaxis, VIT is of utmost …

Abstract Purpose of Review Venom immunotherapy has been utilized to treat Hymenoptera
venom allergy since the 1920s. Over the last century, significant advances in the fields of …